uk renal registry 17th annual report figure 8.1. percentage of haemodialysis patients with phosphate...
TRANSCRIPT
![Page 1: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/1.jpg)
UK Renal Registry 17th Annual Report
Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1– 1.7 mmol/L) by centre in 2013
![Page 2: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/2.jpg)
UK Renal Registry 17th Annual Report
Figure 8.2. Funnel plot of percentage of haemodialysis patients with phosphate within the range specified by the RA clinical
audit measure (1.1–1.7 mmol/L) by centre in 2013
![Page 3: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/3.jpg)
UK Renal Registry 17th Annual Report
Figure 8.3. Percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2013
![Page 4: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/4.jpg)
UK Renal Registry 17th Annual Report
Figure 8.4. Funnel plot of percentage of peritoneal dialysis patients with phosphate within the range specified by the RA
clinical audit measure (1.1–1.7 mmol/L) by centre in 2013
![Page 5: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/5.jpg)
UK Renal Registry 17th Annual Report
Figure 8.5. Longitudinal change in percentage of patients with phosphate below, within and above the 2010 RA
standard by dialysis modality 2003–2013
![Page 6: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/6.jpg)
UK Renal Registry 17th Annual Report
Figure 8.6. Percentage of haemodialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013
![Page 7: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/7.jpg)
UK Renal Registry 17th Annual Report
Figure 8.7. Funnel plot of percentage of haemodialysis patients with adjusted calcium
within range (2.2–2.5 mmol/L) by centre in 2013
![Page 8: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/8.jpg)
UK Renal Registry 17th Annual Report
Figure 8.8. Percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2013
![Page 9: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/9.jpg)
UK Renal Registry 17th Annual Report
Figure 8.9. Funnel plot of percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L)
by centre in 2013
![Page 10: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/10.jpg)
UK Renal Registry 17th Annual Report
Figure 8.10. Longitudinal change in percentage of patients with adjusted calcium <2.2 mmol/L, 2.2–2.5 mmol/L and
>2.5 mmol/L by dialysis modality 2003–2013
![Page 11: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/11.jpg)
UK Renal Registry 17th Annual Report
Figure 8.11. Percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2013
![Page 12: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/12.jpg)
UK Renal Registry 17th Annual Report
Figure 8.12. Funnel plot of percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in
2013
![Page 13: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/13.jpg)
UK Renal Registry 17th Annual Report
Figure 8.13. Percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013
![Page 14: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/14.jpg)
UK Renal Registry 17th Annual Report
Figure 8.14. Funnel plot of percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2013
![Page 15: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/15.jpg)
UK Renal Registry 17th Annual Report
Figure 8.15. Longitudinal change in percentage of patients with PTH within range (16–72 pmol/L) by dialysis modality 2003–2013
![Page 16: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/16.jpg)
UK Renal Registry 17th Annual Report
Figure 8.16. Percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013
![Page 17: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/17.jpg)
UK Renal Registry 17th Annual Report
Figure 8.17. Percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013
![Page 18: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/18.jpg)
UK Renal Registry 17th Annual Report
Figure 8.18. Funnel plot for percentage of HD patients achieving simultaneous control of all three BMD
parameters in preventing severe hyperparathyroidism by centre in 2013
![Page 19: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/19.jpg)
UK Renal Registry 17th Annual Report
Figure 8.19. Funnel plot for percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2013
![Page 20: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/20.jpg)
UK Renal Registry 17th Annual Report
Figure 8.20. Percentage of haemodialysis patients with serum bicarbonate within range (18–24 mmol/L) by centre in 2013
![Page 21: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/21.jpg)
UK Renal Registry 17th Annual Report
Figure 8.21. Funnel plot for percentage of haemodialysis patientswithin the range for bicarbonate (18–24 mmol/L) by centre in 2013
![Page 22: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/22.jpg)
UK Renal Registry 17th Annual Report
Figure 8.22. Percentage of peritoneal dialysis patients with serum bicarbonate within range (22–30 mmol/L) by centre in 2013
![Page 23: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/23.jpg)
UK Renal Registry 17th Annual Report
Figure 8.23. Funnel plot for percentage of peritoneal dialysis patients within the range for bicarbonate (22–30 mmol/L) by centre in 2013
![Page 24: UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader031.vdocuments.net/reader031/viewer/2022032523/56649d8c5503460f94a73d19/html5/thumbnails/24.jpg)
UK Renal Registry 17th Annual Report
Figure 8.24. Longitudinal change in percentage of patients within the range for bicarbonate (18–24 mmol/L for HD and 22–30 mmol/L for PD)
by dialysis modality 2003–2013